Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London
ET
Electra Therapeutics, Inc. ETRA
$8.39
▲ +2.07%
(+$0.17)
Open
$8.06
Prev Close
$8.22
Day Range
$7.93 – $8.87
52W Range
$6.87 – $15.50
Market Cap
$515.94M
Beta
-2.61
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2026-09-18 |
| Shares Out. | 62,770,000 |
| Website | electra-therapeutics.com ↗ |
| Phone | 18887432290 |
About Electra Therapeutics, Inc.
Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.
Electra Therapeutics, Inc. is a publicly traded company under the ticker symbol ETRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-11-01)